Physician profile
Robert Jones
NPI 1629392410
$11,987.56
in general payments reported to CMS, 2019-2025
35 companies · $1,823 in 2025
The $1,823 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $915 · 2020: $1,222 · 2021: $1,369 · 2022: $1,452 · 2023: $4,582 · 2024: $624 · 2025: $1,823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,534 · Food and Beverage: $2,496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,533.62 |
| Food and Beverage | $2,496.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,831.07 | 2023-2025 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $2,135.37 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $877.99 | 2019-2024 | Fasenra, Tezspire, Tagrisso |
| Actelion Pharmaceuticals US, INC. | $858.51 | 2019-2025 | Uptravi, Opsumit |
| Insmed, INC. | $530.47 | 2019-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $402.15 | 2019-2022 | |
| Grifols USA, LLC | $280.32 | 2019-2023 | Prolastin-C Liquid |
| Electromed, INC. | $225.77 | 2021-2023 | Smartvest |
| Baxter Healthcare | $216.93 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Takeda Pharmaceuticals U.S.A., INC. | $182.02 | 2020-2024 | Glassia |
| Axsome Therapeutics, INC. | $149.47 | 2022-2023 | Sunosi |
| Sunovion Pharmaceuticals INC. | $141.49 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $133.24 | 2022-2024 | Dupixent |
| Genzyme Corporation | $127.47 | 2021-2024 | |
| Advanced Respiratory, INC | $115.42 | 2019-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $95.12 | 2019-2023 | Yupelri |
| Abbvie INC. | $91.46 | 2021-2024 | |
| Jazz Pharmaceuticals INC. | $90.64 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $78.47 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $71.80 | 2023-2024 | Purified Cortrophin Gel |
| Circassia INC. | $54.78 | 2019 | |
| Amgen INC. | $34.58 | 2023-2024 | Tezspire |
| Genentech USA, INC. | $33.61 | 2022 | |
| Breas Medical, INC. | $24.46 | 2025 | Vivo 45 Ls |
| Ethicon INC. | $23.51 | 2022 | |
| United Therapeutics Corporation | $22.65 | 2020 | |
| Inogen, INC. | $21.99 | 2022 | |
| Mallinckrodt Hospital Products INC. | $21.32 | 2024 | Acthar |
| Pfizer INC. | $20.33 | 2022 | |
| Resmed Corp | $19.81 | 2020 | |
| Olympus America INC. | $18.10 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.61 | 2022 | |
| Philips North America LLC | $15.68 | 2021 | |
| Merit Medical Systems INC | $12.45 | 2024 | Aspira |
| Cumberland Pharmaceuticals, INC. | $11.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.